Primary Record
CEFPODOXIME
- In stock
- 6,162 g
- Purity
- 99.5 %
- CAS
- 80210-62-4
Compound Identifiers & Properties
- CAS
- 80210-62-4
- PubChem CID
- 6335986
- SMILES
- COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O
- Canonical SMILES
- COCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1
Names & Synonyms
- CEFPODOXIME
- Cefpodoxime acid
- Cefpodoximum
- Cefpodoxima
- Epoxim
- Vantin
- 80210-62-4
- Cefpodoxim acid
- Cefpodoxim
- Banan
- Doxef
- Cefpodoxime sodium salt
- Orelox Paed
- cefpodoxime proxetil
- Cefpodoximum [Latin]
- Cefpodoxima [Spanish]
- Cefpodoxime (INN)
- Cefpodoxime sodium
- Epoxim (TN)
- CPDX
- Sodium, Cefpodoxime
- Cefpodoxime [INN:BAN]
- CPDX-PR
- Vantin (TN)
- 7R4F94TVGY
- Cefpodoxime (Standard)
- Cefpodoxime, Free Acid
- RefChem:56372
- UNII-7R4F94TVGY
- CEFPODOXIME [MI]
- Salt, Cefpodoxime Sodium
- Sodium Salt, Cefpodoxime
- CEFPODOXIME [INN]
- CEFPODOXIME [JAN]
- CHEMBL1672
- D0W6CA
- AC1O3S8J
- CHEBI:3504
- MFCD00864906
- SCHEMBL27072
- CEFPODOXIME [WHO-DD]
- Cefpodoxime Proxetil EP Impurity A
- DTXSID6022765
- UNII-3ULP5169B3
- C15H17N5O6S2
- C15H17N5O6S2.Na
- DTXCID402765
- orb1302380
- HEXADECYL2-ETHYLHEXANOATE
- GTPL10780
- HY-A0251R
- RU 51807
- HY-A0251
- MSK12018
- BBF-03948
- BDBM50292251
- EBC-27060
- ZINC38321403
- RU-51746
- AKOS016008786
- C15-H17-N5-O6-S2.Na
- AC19866
- C15-H17-N5-O6-S2
- CID6335986
- DB01416
- RU51746
- NCGC00532497-01
- (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 253A
- MS-27549
- RU 51746
- U 76253A
- U-76
- U76,253A
- C08114
- Cefpodoxime 100 microg/mL in Acetonitrile
- R-3746
- R-3763
- 51746, RU
- 76253A, U
- J126.228I
- TL8005407
- U 76,253A
- U-76,253A
- CS-0017595
- FT-0664435
- NS00007355
- R3746
- 82619-04-3
- D07650
- G76768
- R 3746
- R 3763
- Cefpodoxime, VETRANAL(TM), analytical standard
- 210C624
- 3746, R
- EN300-22411570
- F980313
- Q415173
- SR-01000872579
- A1179022
- SR-01000872579-1
- CEFPODOXIME PROXETIL IMPURITY A [EP IMPURITY]
- (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (+)-(6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)-2-((Z)-METHOXYIMINO)ACETAMIDO)-3-(METHOXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID
- (+)-(6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO)-3-(METHOXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7(SUP 2)-(Z)-(O-METHYLOXIME)
- (6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- (6R,7R)-7-((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7-[[(2Z)-2-(2-AMINO-4-THIAZOLYL)-2-(METHOXYIMINO)ACETYL]AMINO]-3-(METHOXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID
- (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R,7R)-7alpha-[[(2-Amino-4-thiazolyl)[(Z)-methoxyimino]acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]octa-2-ene-2-carboxylic acid
- (6R,7R)-7alpha-[[(2-Aminothiazol-4-yl)[(Z)-methoxyimino]acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-methoxyiminoacetyl]amino]-3-methoxymethylcepham-3-ene-4-carboxylic acid
- 4-{((R)-2-Carboxy-3-methoxymethyl-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-en-7-ylcarbamoyl)-[(Z)-methoxyimino]-methyl}-thiazol-2-yl-ammonium
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, (6R-(6alpha,7beta(Z)))-
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(Z)))-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, [6R-[6a,7ss(Z)]]-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, (6R,7R)- (9CI); (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefpodoxime; Cefpodoxime acid; R 3763
- 7-{[(2-amino-1,3-thiazol-4-yl)(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 7-beta-[2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylic acid
- 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylic acid